ATE247909T1 - Getränk mit einem gehalt an alpha-ketoglutarsäure - Google Patents

Getränk mit einem gehalt an alpha-ketoglutarsäure

Info

Publication number
ATE247909T1
ATE247909T1 AT95900974T AT95900974T ATE247909T1 AT E247909 T1 ATE247909 T1 AT E247909T1 AT 95900974 T AT95900974 T AT 95900974T AT 95900974 T AT95900974 T AT 95900974T AT E247909 T1 ATE247909 T1 AT E247909T1
Authority
AT
Austria
Prior art keywords
pct
ketoglutaric acid
composition
date
sec
Prior art date
Application number
AT95900974T
Other languages
English (en)
Inventor
Thomas Olin
Original Assignee
Gramineer Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20391686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE247909(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gramineer Ab filed Critical Gramineer Ab
Application granted granted Critical
Publication of ATE247909T1 publication Critical patent/ATE247909T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/68—Acidifying substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/804—Low calorie, low sodium or hypoallergic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/81—Energy rations, e.g. emergency rations, survival rations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
  • Manufacture Of Tobacco Products (AREA)
AT95900974T 1993-11-09 1994-11-08 Getränk mit einem gehalt an alpha-ketoglutarsäure ATE247909T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303691A SE9303691D0 (sv) 1993-11-09 1993-11-09 New beverage
PCT/SE1994/001048 WO1995012991A1 (en) 1993-11-09 1994-11-08 New beverage

Publications (1)

Publication Number Publication Date
ATE247909T1 true ATE247909T1 (de) 2003-09-15

Family

ID=20391686

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95900974T ATE247909T1 (de) 1993-11-09 1994-11-08 Getränk mit einem gehalt an alpha-ketoglutarsäure

Country Status (12)

Country Link
US (1) US5817364A (de)
EP (1) EP0727947B1 (de)
JP (1) JPH09504945A (de)
CN (1) CN1076183C (de)
AT (1) ATE247909T1 (de)
AU (1) AU685882B2 (de)
CA (1) CA2176134A1 (de)
DE (1) DE69433092D1 (de)
FI (1) FI961947A7 (de)
NO (1) NO314824B1 (de)
SE (1) SE9303691D0 (de)
WO (1) WO1995012991A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025331A1 (en) * 1997-11-13 1999-05-27 University Of Florida Use of ketoacids together with amino acids for enhancing muscle performance and recovery from fatigue
US6214390B1 (en) 1997-11-17 2001-04-10 Robert E. Weinstein Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6013290A (en) * 1997-11-17 2000-01-11 Weinstein; Robert E. Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6514545B1 (en) 1997-11-17 2003-02-04 Robert E. Weinstein Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6221910B1 (en) 1999-07-22 2001-04-24 The University Of New Mexico Glutamine containing oral replacement solution
CN1457255A (zh) * 2001-02-14 2003-11-19 马蒂亚斯·拉特 参与细胞生物能代谢的生物化学化合物的组合物和其使用方法
US6989171B2 (en) * 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
SE0201713D0 (sv) 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
RU2360671C2 (ru) * 2003-07-01 2009-07-10 Эссентис Аб Применение альфа-кетоглутаровой кислоты для лечения недостаточности питания или состояния с высоким уровнем глюкозы в плазме
SE0301947D0 (sv) * 2003-07-01 2003-07-01 Gramineer Internat Ab New method and uses
PL368572A1 (en) * 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
US20060134300A1 (en) * 2004-12-20 2006-06-22 Newman Arnold L Nutritional supplement for caffeine-containing beverages
EP1951218A4 (de) * 2005-11-15 2010-11-10 Entress Ab Medikament zur verwendung in verbindung mit knorpelabbau
NZ572649A (en) * 2006-04-12 2011-03-31 Ranya L Alexander Compositions comprising pyruvate alkyl esters and uses thereof
PL379512A1 (pl) * 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
US7566463B2 (en) * 2006-05-03 2009-07-28 C. B. Fleet Company Oral rehydration compositions
KR20150003908A (ko) * 2007-07-03 2015-01-09 다누타 크루셰프스카 유기 바이오연료의 제조를 위한 알파­케토글루타레이트의 용도
US20100256058A1 (en) * 2007-07-27 2010-10-07 Gilmore Sports Ii, Llc Exercise performance and recovery formulations
EP2098124A1 (de) 2008-03-03 2009-09-09 Nestec S.A. Kohlenhydratgel
US20090280229A1 (en) * 2008-05-07 2009-11-12 Constantine Wendy L Method and apparatus for manufacturing protein beverages
EP2177113A1 (de) * 2008-10-15 2010-04-21 Nestec S.A. Verbesserte Leberglycogen-Synthese
DE102009016119A1 (de) * 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
US20150157660A1 (en) * 2013-12-10 2015-06-11 Lifewave, Inc. Nutritional product composition for energy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE462463C (de) * 1928-07-11 Constanz Petersmann Nachgiebige Streckenauskleidung aus Natursteinen
US4001448A (en) * 1973-05-14 1977-01-04 General Foods Corporation Beverage mix and method of manufacturing same
US4309417A (en) * 1980-07-10 1982-01-05 Stauffer Chemical Company Protein fortified isotonic beverages
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats
SE9201584D0 (sv) * 1992-05-20 1992-05-20 Vinnars Erik Ab Use of alpha-ketoglutarate
US5270297A (en) * 1992-07-23 1993-12-14 Metagenics, Inc. Endurance and rehydration composition

Also Published As

Publication number Publication date
CN1076183C (zh) 2001-12-19
AU685882B2 (en) 1998-01-29
CN1136266A (zh) 1996-11-20
FI961947L (fi) 1996-06-13
WO1995012991A1 (en) 1995-05-18
NO961809D0 (no) 1996-05-03
CA2176134A1 (en) 1995-05-18
SE9303691D0 (sv) 1993-11-09
FI961947A7 (fi) 1996-06-13
US5817364A (en) 1998-10-06
DE69433092D1 (de) 2003-10-02
NO314824B1 (no) 2003-06-02
EP0727947A1 (de) 1996-08-28
JPH09504945A (ja) 1997-05-20
AU1037895A (en) 1995-05-29
FI961947A0 (fi) 1996-05-08
NO961809L (no) 1996-06-24
EP0727947B1 (de) 2003-08-27

Similar Documents

Publication Publication Date Title
ATE247909T1 (de) Getränk mit einem gehalt an alpha-ketoglutarsäure
DE69531457D1 (en) Sulfonamide
ES2123910T3 (es) Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.
DE69317578D1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
ATE196821T1 (de) Synergistische mischung mit 1,2,4-triazolen
AU6617290A (en) Cosmetic deodorants
ATE311844T1 (de) Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
GR3030371T3 (en) Triazole compounds and their use as dopamine-d 3?-ligands
EP0625312A4 (de) Futterzusammensetzung.
IL81887A0 (en) Dihydroisoxazole derivatives,their preparation and pharmaceutical compositions containing them
DE69431601D1 (de) Neue verwendung von dexmedetomidin
DE59409735D1 (de) ALKOXYALKYLCARBAMATE VON IMIDAZO[1,2-a]PYRIDINEN
AU3582095A (en) Isothiourea derivatives as no synthase inhibitors
WO2002003974A3 (en) Composition comprising folic acid and zinc for improving male fertility
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
ATE226058T1 (de) Verwendung von lysin zur behandlung des haarausfalls
GB9326302D0 (en) Effluent treatment
ATE123415T1 (de) Behandlung anstrengungsbedingter pulmonarer blutungen bei tieren.
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
CA2325282A1 (en) Use of apo b secretion/mtp inhibitors
AU3295495A (en) Method for the treatment or prophylaxis of endo- and ectoparasitic infestations in dogs
NZ240392A (en) Calcium borate/amino carboxylate corrosion inhibitors: coating formulations
IL108283A0 (en) Use of riluzole for promoting restoration following radiation
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties